Posters

31. Assessing Device Compatibility Through Assay Matrix Approach Ensures Therapeutic Consistency, Patient Welfare 1/7/2025

    Apply these findings to enhance drug product handling protocols and ensure the safety and efficacy of clinical trial outcomes.

32. Guidelines And Strategies For The Development, Qualification Of Potency Assay 1/7/2025

    Explore key strategies and guidelines to advance the development and qualification of robust potency assays for gene therapy products.

33. Successful Capture DoE Studies For A Range Of AAV Serotypes 1/7/2025

    The findings presented here highlight critical strategies for optimizing AAV manufacturing processes, ensuring both quality and cost-effectiveness in gene therapy applications.

34. Qualification Of An mRNA Expression Assay For GOI, Stability Insights, And Process Evolution Detection 12/18/2024

    Learn how our qualified potency assay ensures precise and reliable evaluation of gene therapy vectors, supporting consistency and compliance across development phases.

35. Advancements In Nanopore Sequencing Allow In-Depth Characterization Of rAAV Vector Batches Comparable To SMRT™ Sequencing 12/18/2024

    Discover how advanced long-read sequencing technologies can optimize rAAV quality assessment and enhance gene therapy platform development.

36. Streamlined Pre-Formulation Screening With Minimal Sample Requirements & 2-Day Turnaround To Enable High Efficiency AAV Formulation Development 12/18/2024

    See how optimizing pH and NaCl concentrations can enhance protein stability and performance in biotechnological applications by reviewing our detailed findings.

37. A Single QC Assay To Quantify Two Plasmid Impurities Across Several Serotypes Reduces Time, Costs 12/18/2024

    Explore how this dual-function assay enhances QC efficiency in rAAV production by simultaneously quantifying key plasmid impurities.

38. Considerations For AVV Analytical Comparability Studies For Products With Low Batch Numbers 12/18/2024

    Explore the detailed strategies and practical insights presented in this study to enhance analytical comparability for AAV products with limited batch numbers.

39. From Chemical To Mechanical: A Comparative Analysis Of Cell Lysis Strategies For Mammalian Cells 12/18/2024

    This study investigates the efficiency and effectiveness of various lysis methods for Adeno-Associated Virus (AAV) recovery, focusing on optimizing capsid and vector genome (Vg) yields across multiple AAV serotypes.